Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Garten, R. J
Right arrow Articles by Yu, X.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garten, R. J
Right arrow Articles by Yu, X.-F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Volume 33, Number 1, pp. 182-188
IJE vol.33 no.1 © International Epidemiological Association 2004; all rights reserved.


Infectious Diseases

Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China

Rebecca J Garten1, Shenghan Lai2, Jinbing Zhang2, Wei Liu3, Jie Chen3, David Vlahov4 and Xiao-Fang Yu1

1 Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
2 Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
3 Guangxi Centers for Disease Control and Prevention, Guangxi Province, China
4 Center for Urban Epidemiological Studies, New York Academy of Medicine, New York, New York, USA

Correspondence: Xiao-Fang Yu, Associate Professor MMI, JHBSPH E5148, Baltimore, MD 21205, USA. Email: xfyu{at}jhsph.edu

Background Hepatitis C virus (HCV) is quickly spread through injection drug use. The prevalence and incidence of HCV in Chinese heroin users has been rarely reported.

Methods A longitudinal cohort of young injection drug users (IDU) from southern China was established to study the risk factors for blood-borne infections (597 subjects). Individuals underwent analysis for the presence of hepatitis B surface antigen and antibodies to human immunodeficiency virus type 1 (HIV-1), HCV and hepatitis B surface antigen. Using self-reported risk behaviours, multivariate regression analysis was performed for factors associated with HCV prevalence and seroconversion.

Results At baseline, HIV-1 and HCV prevalence was 17% and 72%, respectively. Significant factors associated with HCV seroprevalence included age >25 years (odds ratio [OR] = 1.71) and injection drug use for >2 years (OR = 2.60). HCV prevalence within one year of starting heroin use was 57% for any route of administration, and 80% if restricted to injectors. After two 6-month follow-up visits, 56 out of 159 baseline HCV seronegative individuals (148.9 total person years [py]), underwent seroconversion at an incidence rate of 37.6 per 100 py. Individuals who reported injection drug use were more likely to undergo HCV seroconversion (rate ratio [RR] = 6.59).

Conclusions HCV infection is rapidly acquired in heroin users who adopt injection in southern China. This study emphasizes the urgent need to implement and expand injection prevention and primary substance abuse prevention programmes in China.


Keywords Hepatitis C, injection drug use, substance abuse, China, heroin, epidemiology, prevalence, risk factors, prevention, logistic model

Accepted 20 August 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
K. Page-Shafer, B. L. Pappalardo, L. H. Tobler, B. H. Phelps, B. R. Edlin, A. R. Moss, T. L. Wright, D. J. Wright, T. R. O'Brien, S. Caglioti, et al.
Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates
J. Clin. Microbiol., February 1, 2008; 46(2): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
L Degenhardt, W Hall, and M Warner-Smith
Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS
Sex. Transm. Inf., June 1, 2006; 82(suppl_3): iii56 - iii63.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. Nakano, L. Lu, Y. He, Y. Fu, B. H. Robertson, and O. G. Pybus
Population genetic history of hepatitis C virus 1b infection in China
J. Gen. Virol., January 1, 2006; 87(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C.-Q. Wang, Y. Li, S. D. Douglas, X. Wang, D. S. Metzger, T. Zhang, and W.-Z. Ho
Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression
Am. J. Pathol., November 1, 2005; 167(5): 1333 - 1340.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.